Stay updated on AFPᶜ³³²T Reduces AFP in Adv HCC Clinical Trial
Sign up to get notified when there's something new on the AFPᶜ³³²T Reduces AFP in Adv HCC Clinical Trial page.

Latest updates to the AFPᶜ³³²T Reduces AFP in Adv HCC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page now shows revision v3.5.4, replacing v3.5.3. This indicates a small site update without changes to study information.SummaryDifference0.0%

- Check23 days agoNo Change Detected
- Check37 days agoChange DetectedThe page’s UI release/version indicator has been updated from Revision v3.5.2 to Revision v3.5.3.SummaryDifference0.0%

- Check44 days agoChange DetectedAdded Revision: v3.5.2; Deleted Revision: v3.5.0.SummaryDifference0.0%

- Check73 days agoChange DetectedAdded a new resources entry for Hepatocellular carcinoma and a link to the Genetic and Rare Diseases Information Center. Site revision updated from v3.4.3 to v3.5.0.SummaryDifference0.2%

- Check80 days agoChange DetectedUpdated the page revision to v3.4.3 by adding the new revision entry and removing the previous v3.4.2 entry.SummaryDifference0.0%

- Check109 days agoChange DetectedThe page’s revision label updated from v3.4.1 to v3.4.2, with no changes to study details, eligibility criteria, or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to AFPᶜ³³²T Reduces AFP in Adv HCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AFPᶜ³³²T Reduces AFP in Adv HCC Clinical Trial page.